The Clinical and Cost-Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia: an Evidence Review Group Evaluation of a NICE Single Technology Appraisal: Inotuzumab for the treatment of adult R/R B-cell ALL: an ERG perspective

Search results

• Finished

  NETSCC: TARS - Production of Technology Assessment Reviews for the NIHR

  Stewart, L. (Principal investigator), Bojke, L. (Co-investigator), Craig, D. (Co-investigator), Eastwood, A. J. (Co-investigator), Griffin, S. (Co-investigator), Higgins, J. P. T. (Co-investigator), Palmer, S. J. (Co-investigator), Rothery, C. (Co-investigator), Sculpher, M. (Co-investigator), Soares, M. O. (Co-investigator), Spackman, E. (Co-investigator), Walker, S. M. (Co-investigator), Woods, B. (Co-investigator) & Woolacott, N. F. (Co-investigator)

  1/04/16 → 31/03/22

  Project: Research project (funded) › Research